Blood-based biomarkers show why diverse groups are underrepresented in Alzheimer's trials, raising questions about risk factors beyond amyloid.
Vous n'êtes pas connecté
Hopolang Mokhopi THE World Health Organisation (WHO) has released guidelines, known as Preferred Product Characteristics (PPC), for blood-based diagnostic tests for Alzheimer’s disease (AD). Developed with a group of 20…
Blood-based biomarkers show why diverse groups are underrepresented in Alzheimer's trials, raising questions about risk factors beyond amyloid.
Some of the communities most at risk for Alzheimer's disease continue to be underrepresented in clinical trials-and new research from the Keck...
The study will recruit 1,100 people from diverse geographic, ethnic, and economic backgrounds, as well as those living with other health conditions.
World Alzheimer's Day 2025: While 21 September is observed as an awareness day for the progressive neurodegenerative disease, the day also serves to...
World Alzheimer's Day 2025: While 21 September is observed as an awareness day for the progressive neurodegenerative disease, the day also serves to...
In a landmark study of Hispanic and Latino adults, researchers at University of California San Diego School of Medicine have identified a link between...
In a landmark study of Hispanic and Latino adults, researchers at University of California San Diego School of Medicine have identified a link between...
Scientists at Emory University’s Goizueta Brain Health Institute and partner institutions have identified proteins in the blood that may shed new...
Researchers at the Mayo Clinic in Rochester, Minnesota, have recently developed a new artificial intelligence (AI) tool that helps clinical care...
Researchers at the Mayo Clinic in Rochester, Minnesota, have recently developed a new artificial intelligence (AI) tool that helps clinical care...